Products
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 121805 | L-778123 hydrochloride | 253863-00-2 | 98% |  |
| L-778123 hydrochloride is an inhibitor of FPTase and GGPTase-I with IC50 of 2 nM and | ||||
| 90102 | Fevipiprant ( NVP-QAW039 ) | 872365-14-5 | ≧98.0% | _872365-14-5.png) |
| Fevipiprant (QAW039; NVP-QAW039) is a selective, potent, reversible competitive CRTh2 | ||||
| 2073106 | Lerociclib HCl (G1T38 HCl) | 2097938-59-3 | ≧98.0% |  |
| Lerociclib HCl (G1T38)is a novel, selective,differentiated oral CDK4/6 inhibitor with | ||||
| S510902 | Cenicriviroc ( TAK-652 ) | 497223-25-3 | 98% Min. |  |
| Cenicriviroc ( TAK-652, TBR-652) is an experimental drug candidate for the treatment | ||||
| 1711222 | Asciminib ( ABL001 ) | 1492952-76-7 | 99.35% |  |
| Asciminib, Bulk in stock, contact us by email for the quotation. Kg scale intermediat | ||||
| 18381 | JPH203 HCl ( Nanvuranlat ) | 1597402-27-1 | ≧95.0% | _1597402-27-1.png) |
| JPH203, also known as KYT-0353, is a potent and selective LAT1 selective ( L-type ami | ||||
| 18382 | eCF506 ( NXP 900 ) | 1914078-41-3 | ≧98.0% |  |
| eCF506 targets a molecule called Src tyrosine kinase that is required for breast canc | ||||
| 18435 | Ritlecitinib ( PF-06651600 ) | 1792180-81-4 | ≧98.0% |  |
| Ritlecitinib ( PF-06651600 ) is a potent and selective JAK3 inhibitor. PF-06651600, a | ||||
| 184321 | Ensartinib ( X396 ) | 1370651-20-9 | >98% |  |
| Ensartinib is an orally available small molecule inhibitor of the receptor tyrosine k | ||||
| 184107 | PF-9366 | 72882-78-1 | ≧98.0% |  |
| PF-9366 is a novel inhibitor of human methionine adenosyltransferase 2A (Mat2A), the | ||||
| 512194 | Lazertinib | 1903008-80-9 | 98% Min. |  |
| Description：Lazertinib is a an orally available third-generation, selective inhibi | ||||
| 185216 | Iberdomide | 1323403-33-3 | >98% |  |
| Iberdomide, also known as CC-220, is potentially for the treatment of systemic lupus | ||||